Relief Therapeutics (OTCMKTS:RLFTF) Shares Down 13.6% – Here’s What Happened

Relief Therapeutics Holding SA (OTCMKTS:RLFTFGet Free Report) shares traded down 13.6% during mid-day trading on Tuesday . The company traded as low as $2.73 and last traded at $2.73. 743 shares changed hands during trading, a decline of 73% from the average session volume of 2,734 shares. The stock had previously closed at $3.16.

Relief Therapeutics Price Performance

The company has a 50-day simple moving average of $3.73 and a 200 day simple moving average of $4.43.

About Relief Therapeutics

(Get Free Report)

Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.

See Also

Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.